BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4362033)

  • 21. [Regaining operability in a case of extensive cancer of the breast].
    Boveri I; Prete R; Tava P; Feltri R; Perduca G; Rapella P; Pacquola MG; Palenzona B
    Minerva Chir; 1986 Oct; 41(19):1559-61. PubMed ID: 3027617
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
    Rivera E; Valero V; Esteva FJ; Syrewicz L; Cristofanilli M; Rahman Z; Booser DJ; Hortobagyi GN
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):299-302. PubMed ID: 11914909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can maitake MD-fraction aid cancer patients?
    Kodama N; Komuta K; Nanba H
    Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of pharmorubicin in cancer of the breast].
    Ass NIa; Borisov VI
    Sov Med; 1986; (10):36-9. PubMed ID: 3544240
    [No Abstract]   [Full Text] [Related]  

  • 25. Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.
    Ernst P; Balslev I; Mouridsen HT
    Cancer Treat Rep; 1987 Oct; 71(10):987-8. PubMed ID: 3652062
    [No Abstract]   [Full Text] [Related]  

  • 26. Ductal carcinoma-in-situ.
    Wickerham DL
    J Clin Oncol; 2001 Sep; 19(18 Suppl):98S-100S. PubMed ID: 11560982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy in breast neoplasms. A review].
    Pedersen H; Larsen V
    Ugeskr Laeger; 1976 Jun; 138(24):1445-9. PubMed ID: 1273972
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen in the treatment of advanced breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1986 Feb; 69(2):96-102. PubMed ID: 3011939
    [No Abstract]   [Full Text] [Related]  

  • 33. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of adriablastin in the combination chemotherapy of disseminated breast cancer].
    Korman DB; Borisov AI; Maslova IA; Pines EV
    Vopr Onkol; 1981; 27(4):44-7. PubMed ID: 7233874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 37. Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?
    Chaturvedi S; McLaren C; Schofield AC; Ogston KN; Sarkar TK; Hutcheon AW; Miller ID; Heys SD
    Breast Cancer Res Treat; 2005 Sep; 93(2):151-8. PubMed ID: 16187235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 39. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lumpectomy and chemotherapy. Unproved method of treating breast cancer.
    Pressman PI
    N Y State J Med; 1981 Nov; 81(12):1765-7. PubMed ID: 6276831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.